69 Best Biotech Startups in United Kingdom to Watch in 2024

Oophthalmic gene therapy company to treat blinding retinal illnesses.

Total Raised: $120.86M

Last Funding: $120.86M (Series A)

Antibody-drug conjugate (ADC) payload platform.

Total Raised: $115.00M

Last Funding: $115.00M (Series A)

Oral antifungal therapy developer to treat life-threatening rare fungal infections

Total Raised: $170.00M

Last Funding: $100.00M (Series D)

Short-duration psychedelic medicines developer for neuropsychiatric conditions.

Total Raised: $43.69M

Last Funding: $40.00M (Series B)

Nuclera is a provider of eProtein discovery benchtop system founded in 2013 by Jiahao Huang, Gordon McInroy and Michael Chen.

Total Raised: $117.50M

Last Funding: $75.00M (Series C)

Developer of immunoglobulin E (IgE) antibodies to treat cancer.

Total Raised: $64.47M

Last Funding: $16.50M (Series B)

Developer of neurostimulation system to treat swallowing dysfunction.

Total Raised: $52.10M

Last Funding: $42.00M (Series D)

Developer of full-spectrum microbial therapeutics.

Total Raised: $51.27M

Last Funding: $0.63M (Seed)

Basecamp Research is an AI-driven protein sequences and biological systems developer founded in 2019 by Glen Gowers.

Total Raised: $80.00M

Last Funding: $60.00M (Series B)

Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).

Total Raised: $36.94M

Last Funding: $24.00M (Series B)

Portfolio of pharmaceutical research and discovery.

Total Raised: $33.50M

Last Funding: $33.50M (Series C)

AI-driven drug discovery platform for rare diseases.

Total Raised: $47.00M

Last Funding: $47.00M (Series C)

Platform for advancing neuroscience and neurophysiology solutions.

Total Raised: $9.11M

Last Funding: $2.66M (Seed)

Discovery and development platform of superior microbial bioproducts.

Total Raised: $7.20M

Last Funding: $0.46M (Seed)

Clinical-stage research for alzheimer’s disease.

Total Raised: $66.45M

Last Funding: $58.65M (Series A)

Naturbeads is a sustainable and biodegradable cellulose ingredients producer founded in 2018 by Giovanna Laudisio.

Total Raised: $11.59M

Last Funding: $9.85M (Series A)

Computational drug discovery platform.

Total Raised: $37.00M

Last Funding: $37.00M (Series B)

Oncology drug discovery platform.

Total Raised: $11.43M

Last Funding: $11.43M (Seed)

RNA sequencing platform.

Total Raised: $10.79M

Last Funding: $10.79M (Seed)

Chemical discovery digitisation platform.

Total Raised: $42.93M

Last Funding: $42.93M (Series A)

Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.

Total Raised: $13.66M

Last Funding: $0.66M (Unknown)

Manufacturing platform designed to help patients access lifesaving treatments.

Total Raised: $130.00M

Last Funding: $100.00M (Series B)

Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers.

Total Raised: $188.00M

Last Funding: $120.00M (Series B)

Gene and cell therapy manufacturing.

Total Raised: $65.90M

Last Funding: $65.90M (Series A)

Oncology treatment plalform.

Total Raised: $35.00M

Last Funding: $35.00M (Series B)

Developer of sustainable plant-based pigments.

Total Raised: $3.20M

Last Funding: $3.20M (Seed)

Clinical trials platform.

Total Raised: $22.80M

Last Funding: $18.00M (Series A)

Advanced cell analysis solution for the biopharma industry.

Total Raised: $7.05M

Last Funding: $5.11M (Series A)

Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

Total Raised: $201.00M

Last Funding: $17.00M (Seed)

Anti-cancer drug developer.

Total Raised: $28.00M

Last Funding: $28.00M (Series A)

Lab-quality diagnostics for anyone, anywhere, at any time.

Total Raised: $170.00M

Last Funding: $85.00M (Unknown)

Immunotherapy for bladder cancer.

Total Raised: $30.00M

Last Funding: $30.00M (Series B)

DNA synthesis technology researcher.

Total Raised: $24.00M

Last Funding: $24.00M (Series B)

AI-powered drug testing platform.

Total Raised: $1.88M

Last Funding: $1.88M (Pre Seed)

Instruments for non-contact optical research, design, and production.

Total Raised: $1.63M

Last Funding: $1.63M (Seed)

Arthritis treatment using engineered human stem cells.

Total Raised: $1.78M

Last Funding: $1.78M (Seed)

Quantum simulation platform for drug discovery.

Total Raised: $2.24M

Last Funding: $2.24M (Seed)

Platform focused on utilizing the body's natural immune control mechanisms.

Total Raised: $97.04M

Last Funding: $97.04M (Series B)

Precision software for eye surgery.

Total Raised: $8.11M

Last Funding: $8.11M (Seed)

Platform using deep learning on 3D molecular structures to develop treatments for harmful proteins.

Total Raised: $50.00M

Last Funding: $50.00M (Series A)

Digital platform to run in-silico simulations for new and existing medicines.

Total Raised: $1.40M

Last Funding: $1.40M (Seed)

Drug discovery platform focused on restoring mitochondrial function through therapeutic approaches.

Total Raised: $36.92M

Last Funding: $18.19M (Unknown)

Platform for understanding and defining the biological codes that make up human cells.

Total Raised: $144.50M

Last Funding: $103.00M (Series B)

Platform enabling the development of cell therapies through advanced reprogramming techniques.

Total Raised: $13.70M

Last Funding: $10.00M (Series A)

Cell therapy firm specializing in developing treatments using advanced cellular technology.

Total Raised: $201.03M

Last Funding: $156.00M (Series B)

Developer of novel Treg therapies to treat inflammatory disorders.

Total Raised: $0.84M

Last Funding: $0.84M (Pre Seed)

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

Total Raised: $42.50M

Last Funding: $40.00M (Series A)

Platform specializing in developing new, high-yield tropical crop varieties and traits.

Total Raised: $63.50M

Last Funding: $35.00M (Series C)

Biotechnology platform focused on rejuvenating transplant livers.

Total Raised: $39.75M

Last Funding: $30.00M (Series A)

Pet therapeutics startup dedicated to developing medicines for pets.

Total Raised: $50.00M

Last Funding: $37.00M (Series B)

Building the future of food, starting with dairy.

Total Raised: $24.13M

Last Funding: $22.00M (Unknown)

Small molecules to increase tumor detection by the immune system.

Total Raised: $56.30M

Last Funding: $50.00M (Series B)

Sea-weed based bioplastic packaging.

Total Raised: $4.14M

Last Funding: $3.70M (Seed)

New drug application (NDA) IB1001 developer for the treatment of Niemann-pick disease type C (NPC).

Total Raised: $50.57M

Last Funding: $40.27M (Series B)

Molecular diagnostics provider offering rapid and accurate disease testing solutions.

Total Raised: $63.27M

Last Funding: $50.00M (Series B)

Platform for analyzing single molecules like DNA, RNA, and proteins using nanopore-based electronic systems.

Total Raised: $275.13M

Last Funding: $275.13M (Unknown)

Biopharmaceutical company developing protein therapeutics with a machine learning-driven evolution engine.

Total Raised: $83.17M

Last Funding: $3.70M (Seed)

Human microbiome therapeutics developer creating live bacterial treatments and biomarkers.

Total Raised: $66.55M

Last Funding: $66.55M (Unknown)

Advanced membrane tech for water filters.

Total Raised: $6.86M

Last Funding: $6.86M (Series A)

The food chain is broken. Our technology fixes it.

Total Raised: $19.79M

Last Funding: $16.00M (Series A)

Genomic data analysis platform.

Total Raised: $2.20M

Last Funding: $2.20M (Seed)

Plant-based, meatless products.

Total Raised: $51.81M

Last Funding: $0.57M (Seed)

Platform to automate the clinical studies process.

Total Raised: $12.43M

Last Funding: $12.43M (Series A)

Supply chain platfrom for pharma.

Total Raised: $6.54M

Last Funding: $6.54M (Series A)

Oncolytic viral therapies developer.

Total Raised: $53.92M

Last Funding: $23.62M (Series B)

Diagnostic device designed to reduce deaths from drug-resistant infections.

Total Raised: $3.13M

Last Funding: $3.13M (Seed)

Antibody drug discovery platform.

Total Raised: $3.01M

Last Funding: $3.01M (Seed)

Digital-twin simulator.

Total Raised: $3.10M

Last Funding: $3.10M (Pre Seed)

Preclinical stage treatment for geographic atrophy.

Total Raised: $78.97M

Last Funding: $78.97M (Series A)